COVID-19 and persons with substance use disorders: Inequities and mitigation strategies

Osnat C. MelamedAddictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; ;Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada;

http://orcid.org/0000-0002-9663-2226

, MD, MSc

Tanya S. HauckAddictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; ;Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada;

, MD, PhD,

Leslie BuckleyAddictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; ;Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada;

, MD, MPH,

Peter SelbyAddictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; ;Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada; ;Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; ;Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, CanadaCorrespondence[email protected]

http://orcid.org/0000-0001-5401-2996

, MBBS, MHSc

Benoit H. MulsantAddictions Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; ;Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada;

, MD, MS

Abstract

The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.

Keywords:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

COVID-19 and persons with substance use disorders: Inequities and mitigation strategies

Information for

Open access

Opportunities

Help and information

COVID-19 and persons with substance use disorders: Inequities and mitigation strategies

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature